Article
Polygenic risk scores for autoimmune related diseases are significantly different and skewed in cancer exceptional responders
2023-11-30
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold> A small number of cancer patients respond exceptionally well to therapies and survive significantly longer than patients with similar diagnoses. Profiling the genetic backgrounds of exceptional responder (ER) patients can yield insights into the germline polymorphisms that influence response to therapy. As ERs showed a high incidence in autoimmune diseases, we hy...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- abd8c996-50c2-59b9-a1d8-a62651ab2245
- DOI
- 10.21203/rs.3.rs-3476528/v1
